Permanent Injunction against PharmaFab Inc., PFab LP prescription and otc drugs

09 Mar Permanent Injunction against PharmaFab Inc., PFab LP prescription and otc drugs

FDA announced the entry of a Consent Decree of Permanent Injunction against PharmaFab Inc., its subsidiary, PFab LP, and two company officials, to stop the illegal manufacture and distribution of prescription and over-the-counter drug products. The products are illegal because they are not produced according to the required current good manufacturing practice (CGMP) and many also lack required FDA approval. Compliance with CGMP is necessary to ensure that drugs have the requisite safety, identity, strength, quality, and purity.

PharmaFab is a major contract manufacturer and distributor of more than 100 different prescription and over-the-counter drug products, including cough and cold products, ulcer treatments, and postpartum hemorrhage products. Consumers who have products manufactured by PharmaFab should consult with their physician.